Cargando…

Impaired Cav-1 expression in SSc mesenchymal cells upregulates VEGF signaling: a link between vascular involvement and fibrosis

BACKGROUND: Systemic sclerosis (SSc) is characterized by vascular alteration and fibrosis, the former probably leading to fibrosis via the ability of both endothelial cells and pericytes to differentiate toward myofibroblast. It is well known that vascular endothelial growth factor A (VEGF-A, hereaf...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cipriani, Paola, Di Benedetto, Paola, Capece, Daria, Zazzeroni, Francesca, Liakouli, Vasiliki, Ruscitti, Piero, Pantano, Ilenia, Berardicurti, Onorina, Carubbi, Francesco, Alesse, Edoardo, Giacomelli, Roberto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4166421/ https://www.ncbi.nlm.nih.gov/pubmed/25237397 http://dx.doi.org/10.1186/1755-1536-7-13

Ejemplares similares

The Role of IL-1β in the Bone Loss during Rheumatic Diseases
por: Ruscitti, Piero, et al.
Publicado: (2015)

Macitentan inhibits the transforming growth factor-β profibrotic action, blocking the signaling mediated by the ETR/TβRI complex in systemic sclerosis dermal fibroblasts
por: Cipriani, Paola, et al.
Publicado: (2015)

Searching for a good model for systemic sclerosis: the molecular profile and vascular changes occurring in UCD-200 chickens strongly resemble the early phase of human systemic sclerosis
por: Cipriani, Paola, et al.
Publicado: (2016)

Adipocytokines in Rheumatoid Arthritis: The Hidden Link between Inflammation and Cardiometabolic Comorbidities
por: Ruscitti, Piero, et al.
Publicado: (2018)

Epidermal Growth Factor Like-domain 7 and miR-126 are abnormally expressed in diffuse Systemic Sclerosis fibroblasts
por: Liakouli, Vasiliki, et al.
Publicado: (2019)

Managing Adult-onset Still's disease: The effectiveness of high-dosage of corticosteroids as first-line treatment in inducing the clinical remission. Results from an observational study
por: Ruscitti, Piero, et al.
Publicado: (2019)

Impaired Endothelium-Mesenchymal Stem Cells Cross-talk in Systemic Sclerosis: a Link Between Vascular and Fibrotic Features
por: Cipriani, Paola, et al.
Publicado: (2014)

Poor clinical response in rheumatoid arthritis is the main risk factor for diabetes development in the short-term: A 1-year, single-centre, longitudinal study
por: Ruscitti, Piero, et al.
Publicado: (2017)

Efficacy and safety of rituximab treatment in early primary Sjögren's syndrome: a prospective, multi-center, follow-up study
por: Carubbi, Francesco, et al.
Publicado: (2013)

Mesenchymal stem cells of Systemic Sclerosis patients, derived from different sources, show a profibrotic microRNA profiling
por: Di Benedetto, Paola, et al.
Publicado: (2019)

Efficacy of inhibition of IL-1 in patients with rheumatoid arthritis and type 2 diabetes mellitus: two case reports and review of the literature
por: Ruscitti, Piero, et al.
Publicado: (2015)

Increased Cardiovascular Events and Subclinical Atherosclerosis in Rheumatoid Arthritis Patients: 1 Year Prospective Single Centre Study
por: Ruscitti, Piero, et al.
Publicado: (2017)

IL-1 inhibition improves insulin resistance and adipokines in rheumatoid arthritis patients with comorbid type 2 diabetes: An observational study
por: Ruscitti, Piero, et al.
Publicado: (2019)

Blocking CD248 molecules in perivascular stromal cells of patients with systemic sclerosis strongly inhibits their differentiation toward myofibroblasts and proliferation: a new potential target for antifibrotic therapy
por: Di Benedetto, Paola, et al.
Publicado: (2018)

Adult-onset Still’s disease: evaluation of prognostic tools and validation of the systemic score by analysis of 100 cases from three centers
por: Ruscitti, Piero, et al.
Publicado: (2016)

Prevalence of type 2 diabetes and impaired fasting glucose in patients affected by rheumatoid arthritis: Results from a cross-sectional study
por: Ruscitti, Piero, et al.
Publicado: (2017)

Severe COVID-19, Another Piece in the Puzzle of the Hyperferritinemic Syndrome. An Immunomodulatory Perspective to Alleviate the Storm
por: Ruscitti, Piero, et al.
Publicado: (2020)

Incidence of venous thromboembolism in rheumatoid arthritis, results from a “real-life” cohort and an appraisal of available literature
por: Conforti, Alessandro, et al.
Publicado: (2021)

Parenchymal lung disease in adult onset Still’s disease: an emergent marker of disease severity—characterisation and predictive factors from Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale (GIRRCS) cohort of patients
por: Ruscitti, Piero, et al.
Publicado: (2020)

Association Between Minor Salivary Gland Biopsy During Sjӧgren’s Syndrome and Serologic Biomarkers: A Systematic Review and Meta-Analysis
por: Berardicurti, Onorina, et al.
Publicado: (2021)

Interleukin-32 in systemic sclerosis, a potential new biomarker for pulmonary arterial hypertension
por: Di Benedetto, Paola, et al.
Publicado: (2020)

Blocking Jak/STAT signalling using tofacitinib inhibits angiogenesis in experimental arthritis
por: Di Benedetto, Paola, et al.
Publicado: (2021)

Pro-inflammatory properties of H-ferritin on human macrophages, ex vivo and in vitro observations
por: Ruscitti, Piero, et al.
Publicado: (2020)

Lung involvement in macrophage activation syndrome and severe COVID-19: results from a cross-sectional study to assess clinical, laboratory and artificial intelligence–radiological differences
por: Ruscitti, Piero, et al.
Publicado: (2020)

Tofacitinib May Inhibit Myofibroblast Differentiation from Rheumatoid-Fibroblast-like Synoviocytes Induced by TGF-β and IL-6
por: Ruscitti, Piero, et al.
Publicado: (2022)

Cytokine storm syndrome in severe COVID-19
por: Ruscitti, Piero, et al.
Publicado: (2020)

Different operators and histologic techniques in the assessment of germinal center-like structures in primary Sjögren’s syndrome minor salivary glands
por: Carubbi, Francesco, et al.
Publicado: (2019)

Targeting Costimulatory Molecules to Improve Antitumor Immunity
por: Capece, Daria, et al.
Publicado: (2012)

Rheumatic manifestations of COVID-19: a systematic review and meta-analysis
por: Ciaffi, Jacopo, et al.
Publicado: (2020)

Unenhanced Cardiac Magnetic Resonance may improve detection and prognostication of an occult heart involvement in asymptomatic patients with systemic sclerosis
por: Palumbo, Pierpaolo, et al.
Publicado: (2022)

The Pathogenic Role of Interferons in the Hyperinflammatory Response on Adult-Onset Still’s Disease and Macrophage Activation Syndrome: Paving the Way towards New Therapeutic Targets
por: Di Cola, Ilenia, et al.
Publicado: (2021)

Serum Biomarkers Identification by Mass Spectrometry in High-Mortality Tumors
por: Tessitore, Alessandra, et al.
Publicado: (2013)

The Inflammatory Microenvironment in Hepatocellular Carcinoma: A Pivotal Role for Tumor-Associated Macrophages
por: Capece, Daria, et al.
Publicado: (2013)

Editorial: Comorbidities in Psoriatic Arthritis and Their Impact on Therapeutic Strategies
por: Pantano, Ilenia, et al.
Publicado: (2022)

The joint involvement in adult onset Still's disease is characterised by a peculiar magnetic resonance imaging and a specific transcriptomic profile
por: Ruscitti, Piero, et al.
Publicado: (2021)

Life, death, and autophagy in cancer: NF-κB turns up everywhere
por: Verzella, Daniela, et al.
Publicado: (2020)

2-Arachidonoylglycerol Reduces the Production of Interferon-Gamma in T Lymphocytes from Patients with Systemic Lupus Erythematosus
por: Navarini, Luca, et al.
Publicado: (2022)

The assessment of atlantoaxial joint involvement in patients with rheumatoid arthritis, results from an observational “real-life” study
por: Di Muzio, Claudia, et al.
Publicado: (2023)

EV-Mediated Chemoresistance in the Tumor Microenvironment: Is NF-κB a Player?
por: Di Vito Nolfi, Mauro, et al.
Publicado: (2022)

Molecular Mechanisms Underpinning Immunometabolic Reprogramming: How the Wind Changes during Cancer Progression
por: Flati, Irene, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_d4p3i8ind9ocasfqsv202dno4d